901 / 1498
U Modena Experience
Patients and methods:
•
Retrospective analysis of 216 patients treated in 2 trials from
the GISL with 6 x R-CHOP
•
Consolidative/adjuvant IFRT was allowed, at the treating
physician’s discretion, in patients CR/PR on CT
•
Treatment period: 2003-2007
•
Stage III-IV: 65%
•
182 patients achieved CR/PR on CT
•
Stage I-II: 33% received IFRT
•
Stage III-IV:
16%
received IFRT
Marcheselli et al. Leuk Lymphoma, 2011